Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Perrigo Company (PRGO)
:PRGO
Holding PRGO?
Track your performance easily
PRGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.14 - $33.96
Previous CloseN/A
Volume301.70K
Average Volume (3M)1.31M
Market Cap
$3.26B
Enterprise Value$7.01B
Total Cash (Recent Filing)$622.30M
Total Debt (Recent Filing)$5.22B
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Mar 03, 2025EPS Estimate
0.95Last Dividend Ex-Date
Nov 29, 2024Dividend Yield4.63%
Share Statistics
EPS (TTM)-1.11
Shares Outstanding136,427,810
10 Day Avg. Volume1,420,838
30 Day Avg. Volume1,310,783
Standard Deviation0.10
R-Squared0.08
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)19.30
P/FCF Ratio54.20
Enterprise Value/Market Cap2.15
Enterprise Value/Revenue1.60
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda36.28
Forecast
1Y Price Target
$40.00Price Target Upside67.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Perrigo Company News
PremiumCompany Announcements
Perrigo Company Reports Solid Q3 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Business TransformationPerrigo has significant opportunity for stock appreciation as the company continues to reconfigure itself from a generic Rx business to a pureplay consumer self care business.
Financial PerformancePRGO is on track to reach approximately 40% gross margins in FY24, earlier than its original goal of FY25.
Operational EfficiencyPRGO currently has 4 operational initiatives in place to drive efficiencies and margins, including a manufacturing and supply chain optimization program and Project Energize.
Bears Say
Business StrategySales were weaker due to Perrigo exiting some less profitable businesses.
Market PerformanceResults have been volatile, putting the company at a critical juncture.
Sales ForecastManagement reiterated that sales would likely be at the lower end of the forecasted range due to exiting lower-margin businesses and SKU prioritization.
---
Ownership Overview
0.35% Insiders
28.51% Mutual Funds
1.06% Other Institutional Investors
41.93% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRGO FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $23.14 and its highest was $33.96 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is $3.26B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Mar 03, 2025 which is in 42 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on Nov 06, 2024. The company reported $0.81 earnings per share for the quarter, missing the consensus estimate of $0.811 by -$0.001.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company pays a Quarterly dividend of $1.1 which represents an annual dividend yield of 4.63%. See more information on Perrigo Company dividends here
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 0.95.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 136,427,810 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of $0.81 in its last earnings report, missing expectations of $0.811. Following the earnings report the stock price went up 7.726%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in PRGO
---
Perrigo Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$40.00 (67.79% Upside)
$40.00 (67.79% Upside)
Blogger Sentiment
Bullish
PRGO Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 344.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $497.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.25%
12-Months-Change
Fundamentals
Return on Equity
-3.16%
Trailing 12-Months
Asset Growth
4.14%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
---
PRGO Company Deck
---
PRGO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in cost savings and operational efficiencies, particularly in the success of Project Energize and the supply chain reinvention program. However, these positives were counterbalanced by a decline in overall sales and challenges in the U.S. store brand market. Despite these challenges, the company remains optimistic about its strategic initiatives and future growth potential.Read More>---
PRGO Stock 12 Month Forecast
Average Price Target
$40.00
▲(67.79% Upside)
Technical Analysis
Teva Pharmaceutical
―
Dr Reddy's Laboratories
―
Bausch Health Companies
―
Vertex Pharmaceuticals
―
BioMarin Pharmaceutical
―
Regeneron
―
Best Analysts Covering PRGO
1 Year
1 Year Success Rate
3/13 ratings generated profit
1 Year Average Return
-4.91%
reiterated a buy rating 3 months ago
Copying Chris Schott's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -4.91% per trade.
---